[144] SOPHiA GENETICS SA SEC Filing

Rhea-AI Filing Summary

SOPHiA GENETICS SA insider notice shows a proposed sale of 13,486 common shares, with an aggregate market value of $60,282.42, scheduled for 10/03/2025 on NASDAQ. The securities were acquired as Restricted Stock Units on 10/02/2025 from the issuer and the planned broker is Morgan Stanley Smith Barney LLC.
Recent sales by the same beneficial owner under a Rule 10b5-1 plan are disclosed: five separate sales totaling 10,016 shares between 07/07/2025 and 09/19/2025, generating gross proceeds shown per trade. The filer attests there is no undisclosed material adverse information and references Rule 10b5-1 instruction language in the form.

Positive

• 13,486 shares disclosed for sale with aggregate market value $60,282.42
• Securities were acquired as Restricted Stock Units on 10/02/2025, with acquisition date explicitly provided
• Broker for the sale is identified as Morgan Stanley Smith Barney LLC
• Form lists prior 10b5-1 sales (totaling 10,016 shares) with dates and gross proceeds

Negative

• None.

Insights

Corporate Governance Analyst

Insider plans to sell recently vested 13,486 RSU shares via broker on 10/03/2025.

The filing documents a sale of 13,486 shares acquired as Restricted Stock Units on 10/02/2025, to be executed through Morgan Stanley Smith Barney LLC on 10/03/2025. The signer certifies no undisclosed material adverse information and references Rule 10b5-1 language.

This is an administrative insider disclosure required under Rule 144 and does not, by itself, disclose operational or financial changes at the issuer.

Market Compliance Specialist

Filing shows recent pattern of Rule 10b5-1 sales totaling 10,016 shares across five trades.

The schedule of prior sales lists five 10b5-1 transactions from 07/07/2025 to 09/19/2025 with detailed per-trade share counts and gross proceeds. These entries indicate executed automated-plan trades rather than ad-hoc open-market disposals.

The form specifies the sale will occur on NASDAQ and provides the number of shares outstanding (67,579,560) for context in disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13486	60282.42	67579560	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	Restricted Stock Units	Issuer			13486	10/02/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ROSS J MUKEN La Piece 12 ch-1180 Rolle V8 00000	Common	09/19/2025	761	2418.00
10b5-1 Sales for ROSS J MUKEN La Piece 12 ch-1180 Rolle V8 00000	Common	08/19/2025	761	2610.00
10b5-1 Sales for ROSS J MUKEN La Piece 12 ch-1180 Rolle V8 00000	Common	07/23/2025	131	449.33
10b5-1 Sales for ROSS J MUKEN La Piece 12 ch-1180 Rolle V8 00000	Common	07/21/2025	761	2683.06
10b5-1 Sales for ROSS J MUKEN La Piece 12 ch-1180 Rolle V8 00000	Common	07/07/2025	8632	25990.09

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the SOPH Form 144 disclose?

The filing discloses a proposed sale of 13,486 common shares (aggregate value $60,282.42) to occur on 10/03/2025 on NASDAQ.

How were the shares being sold acquired?

The shares were acquired as Restricted Stock Units from the issuer on 10/02/2025 and the filing shows the acquisition date as 10/02/2025.

Which broker will handle the proposed sale?

The proposed sale lists Morgan Stanley Smith Barney LLC (1 New York Plaza, 8th Floor, New York, NY) as the broker.

Does the filing show any recent insider sales?

Yes. The filing lists five prior 10b5-1 sales between 07/07/2025 and 09/19/2025 totaling 10,016 shares with gross proceeds per trade disclosed.

How many shares outstanding does the issuer report in this filing?

The filing reports 67,579,560 shares outstanding.